Allergies are different and their underlying causes also vary. At times, they remain unknown or undetermined by physicians. One can only understand the suffering of an allergic person if they are going through it themselves.
The most painful part of allergies is the reaction that happens internally. People are allergic to certain drugs and for such allergic reaction, physicians prescribe Epinephrine to save them from going into anaphylactic shock, according to CNBC.
The drug is injected via EpiPens, which have recently become highly expensive as the price reaches the $500 mark. The good news for such patients is that epinephrine oral tablets are soon going to be out in the market. The tablet will reportedly dissolve under the tongue.
The dissolving characteristic of this pill will save the patients the trouble of digestion as the tablet will be directly absorbed into the blood. However, there are some concerns for the new Epi-Pill, which is developed by the pharmaceutical researcher Rawas Qalaji. The problem is that even though Epi-Pills are tried and tested and are far easier to consume than the EpiPen, they have not been fully tested on people who experience anaphylaxis.
Moreover, it still remains a bottleneck for researchers to test the effectiveness of the pills without inducing a voluntary anaphylactic shock. Meanwhile, Qalaji had a meeting with FDA and already working on conducting tests based on the rules and regulations provided by the FDA.
Epi-Pen builder company Mylan is already on the verge of protecting their product and declaring that oral epinephrine is non-threatening, according to Seeking Alpha. They also provided examples of other drugs who have much higher prices than Epi-Pens.
One of the reasons cited that are against the Epi-Pills is that FDA has not given them a specific date for their tests and trials. The conflict is still unsettled and can only be resolved once the pills hit the shelves in the market.
